Aiello, T. F. Et Al. 2024. Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.. Haematologica , vol.109 , 2693-2700.

Aiello, T. F., Salmanton-Garcia, J., Marchesi, F., Weinbergerova, B., Glenthoj, A., Van Praet, J., ... Farina, F.(2024). Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.. Haematologica , vol.109, 2693-2700.

Aiello, Tommaso Et Al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.," Haematologica , vol.109, 2693-2700, 2024

Aiello, Tommaso F. Et Al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.." Haematologica , vol.109, pp.2693-2700, 2024

Aiello, T. F. Et Al. (2024) . "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.." Haematologica , vol.109, pp.2693-2700.

@article{article, author={Tommaso Francesco Aiello Et Al. }, title={Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.}, journal={Haematologica}, year=2024, pages={2693-2700} }